Synthesis of novel fluorophenylpyrazole-picolinamide derivatives and determination of their anticancer activity

Shravankumar Kankala, Koteshwar Rao Rama, Chekrapani Kesari, Fredrik Bjorkling, Srinivas Nerella, Prasad Gundepaka, Hanmanthu Guguloth, Niranjan Thota

Research output: Contribution to journalJournal articleResearchpeer-review

2 Citations (Scopus)

Abstract

A series of fluorophenylpyrazole-picolinamide derivatives were synthesized in high yields using a cross-coupling reaction catalyzed byin situformed palladium-N-heterocyclic carbenes (Pd-NHCs). The synthesized novel derivatives were evaluated forin vitroanticancer activity against a panel of four human tumor cell lines, HeLa (cervical), A-549 (lung), MCF-7 (breast), and IMR-32 (neuroblastoma). Four compounds,11c,11e,11j, and11k, showed growth inhibition (low mu M) comparable with the standard drug cisplatin, providing a preliminary structure-activity relationship for the series. The present procedure is operationally simple and works with a wide range of substrates and may thus be useful in further compound optimization.

Original languageEnglish
JournalSynthetic Communications
Volume50
Issue number19
Pages (from-to)2997-3006
Number of pages10
ISSN0039-7911
DOIs
Publication statusPublished - 2020

Keywords

  • Fluorophenylpyrazole-picolinamide
  • cross-coupling
  • palladium-N-heterocyclic carbenes
  • anticancer activity
  • ONE-POT SYNTHESIS
  • BIOLOGICAL EVALUATION
  • PYRAZOLE DERIVATIVES
  • ANTITUMOR AGENTS
  • HYBRIDS
  • DESIGN
  • HETEROCYCLES
  • CANCER

Cite this